High expression of DNA repair pathways is associated with metastasis in melanoma patients
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
We have identified a gene-profile signature for human primary malignant melanoma associated with metastasis to distant sites and poor prognosis. We analyse the differential gene expression by looking at whole biological pathways rather than individual genes. Among the most significant pathways associated with progression to metastasis, we found the DNA replication (P=10(-14)) and the DNA repair pathways (P=10(-16)). We concentrated our analysis on DNA repair and found that 48 genes of this category, among a list of 234 genes, are associated with metastatic progression. These genes belong essentially to the pathways allowing recovery of stalled replication forks due to spontaneous blockage or induced DNA lesions. Because almost all these differentially expressed repair genes were overexpressed in primary tumors with bad prognosis, we speculate that primary melanoma cells that will metastasize try to replicate in a fast and error-free mode. In contrast to the progression from melanocytes to primary melanoma, genetic stability appears to be necessary for a melanoma cell to give rise to distant metastasis. This overexpression of repair genes explains nicely the extraordinary resistance of metastatic melanoma to chemo- and radio-therapy. Our results may open a new avenue for the discovery of drugs active on human metastatic melanoma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, one study has found that OGG1 is overexpressed in some metastatic melanomas73.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [73]
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536 · cited 2×
“The Tumor types Repair Replication Bladder (Dyrskjot et al., 2003) (27) n¼ 29 Carcinoma 6.9 10 3 NS Breast (van’t Veer et al., 2002) (28) n¼ 78 Lymph-node negative primary tumor 1.4 10 2 6.6 10 4 Breast (Wang et al., 2005) (29) n¼ 286 Lymph-node negative primary tumor 4.4 10 3 8.0 10 3 Squamous…”
MethodInfluentialA Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Balch, C. M., Soong, S.-J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,388
The epidemiology of UV induced skin cancer
Armstrong, B. K., & Kricker, A. (2001) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(01)00198-1 · Cited by 1,811 · cited 1×
“The best evidence of a causative link with sun exposure is the association of melanoma with severe episodic sunburn in infancy (Armstrong and Kricker, 2001).”
BackgroundFoxM1 is required for execution of the mitotic programme and chromosome stability
Laoukili, J., Kooistra, M. R. H., Brás, A., Kauw, J., Kerkhoven, R. M., Morrison, A., Clevers, H., & Medema, R. H. (2005) · Nature Cell Biology · doi:10.1038/ncb1217 · Cited by 807
Control of Human Telomere Length by TRF1 and TRF2
Smogorzewska, A., van Steensel, B., Bianchi, A., Oelmann, S., Schaefer, M. R., Schnapp, G., & de Lange, T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1659-1668.2000 · Cited by 768 · cited 1×
“Interestingly, TERF1, specifically involved in telomere maintenance (Smogorzewska et al., 2000), is also overexpressed in Mþ tumor cells.”
BackgroundHowe, H. L., Wingo, P. A., Thun, M. J., Ries, L. A. G., Rosenberg, H. M., Feigal, E. G., & Edwards, B. K. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.11.824 · Cited by 738
Cited by
DNA damage and the balance between survival and death in cancer biology
Roos, W. P., Thomas, A. D., & Kaina, B. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.2 · Cited by 1,189
Fanconi anaemia and cancer: an intricate relationship
Nalepa, G., & Clapp, D. W. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.116 · Cited by 389
Mechanisms and prevention of UV‐induced melanoma
Sample, A., & He, Y. (2018) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/phpp.12329 · Cited by 372
Snyder, A., Nathanson, T., Funt, S. A., Ahuja, A., Buros Novik, J., Hellmann, M. D., Chang, E., Aksoy, B. A., Al-Ahmadie, H., Yusko, E., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002309 · Cited by 341
DNA Damage Response Genes and the Development of Cancer Metastasis
Broustas, C. G., & Lieberman, H. B. (2014) · Radiation Research · doi:10.1667/rr13515.1 · Cited by 275
Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA
Hosono, Y., Niknafs, Y. S., Prensner, J. R., Iyer, M. K., Dhanasekaran, S. M., Mehra, R., Pitchiaya, S., Tien, J., Escara-Wilke, J., Poliakov, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.11.040 · Cited by 235
The mouse ortholog of NEIL3 is a functional DNA glycosylase in vitro and in vivo
Liu, M., Bandaru, V., Bond, J. P., Jaruga, P., Zhao, X., Christov, P. P., Burrows, C. J., Rizzo, C. J., Dizdaroglu, M., & Wallace, S. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908307107 · Cited by 202
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
Røe, O. D., & Stella, G. M. (2015) · European Respiratory Review · doi:10.1183/09059180.00007014 · Cited by 185
Transcriptome Profiling Identifies HMGA2 as a Biomarker of Melanoma Progression and Prognosis
Raskin, L., Fullen, D. R., Giordano, T. J., Thomas, D. G., Frohm, M. L., Cha, K. B., Ahn, J., Mukherjee, B., Johnson, T. M., & Gruber, S. B. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.197 · Cited by 165
Cutaneous Malignant Melanoma: Update on Diagnostic and Prognostic Biomarkers
Abbas, O., Miller, D. D., & Bhawan, J. (2014) · The American Journal of Dermatopathology · doi:10.1097/dad.0b013e31828a2ec5 · Cited by 162
Zhou, J., Fleming, A. M., Averill, A. M., Burrows, C. J., & Wallace, S. S. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv252 · Cited by 148
The Eyes Absent proteins in development and disease
Tadjuidje, E., & Hegde, R. S. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1144-9 · Cited by 160
Melanoma: From Melanocyte to Genetic Alterations and Clinical Options
Bertolotto, C. (2013) · Scientifica · doi:10.1155/2013/635203 · Cited by 197
Targeting DNA repair pathway in cancer: Mechanisms and clinical application
Wang, M., Chen, S., & Ao, D. (2021) · MedComm · doi:10.1002/mco2.103 · Cited by 151
Li, W., & Melton, D. W. (2011) · Oncogene · doi:10.1038/onc.2011.426 · Cited by 131
Hajek, M., Sewell, A. B., Kaech, S. M., Burtness, B. A., Yarbrough, W. G., & Issaeva, N. (2017) · Cancer · doi:10.1002/cncr.30570 · Cited by 127
Mao, Z., Jiang, Y., Liu, X., Seluanov, A., & Gorbunova, V. A. (2009) · Neoplasia · doi:10.1593/neo.09312 · Cited by 127
Kunz, M., Loeffler‐Wirth, H., Dannemann, M., Willscher, E., Doose, G., Kelso, J. F., Kottek, T., Nickel, B., Hopp, L., Landsberg, J., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0385-y · Cited by 127
Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
Harbst, K., Staaf, J., Lauss, M., Karlsson, A., Måsbäck, A., Johansson, I., Bendahl, P.-O., Vallon-Christersson, J., Törngren, T., Ekedahl, H., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0343 · Cited by 105
DNA glycosylases search for and remove oxidized DNA bases
Wallace, S. S. (2013) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21820 · Cited by 104
The convergent roles of the nuclear factor I transcription factors in development and cancer
Chen, K., Lim, J. W. C., Richards, L. J., & Bunt, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.015 · Cited by 110
Conway, C., Mitra, A., Jewell, R., Randerson‐Moor, J. A., Lobo, S., Nsengimana, J., Edward, S., Sanders, D., Cook, M. G., Powell, B. W. E. M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1631 · Cited by 111
Small-Molecule Drugs Mimicking DNA Damage: A New Strategy for Sensitizing Tumors to Radiotherapy
Quanz, M., Berthault, N., Roulin, C., Roy, M., Herbette, A., Agrario, C., Alberti, C., Josserand, V., Coll, J., Sastre‐Garau, X., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2108 · Cited by 115
Dizdaroğlu, M., Coşkun, E., & Jaruga, P. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.02.001 · Cited by 105
Wouters, J., Vizoso, M., Martínez‐Cardús, A., Carmona, F. J., Govaere, O., Laguna, T., Joseph, J., Dynoodt, P., Aura, C. M., Foth, M., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0851-3 · Cited by 109
Overexpression of DNA repair genes is associated with metastasis: A new hypothesis
Sarasin, A. R., & Kauffmann, A. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2007.12.002 · Cited by 101
Self-citationIntratumoral Heterogeneity as a Therapy Resistance Mechanism
Somasundaram, R., Villanueva, J., & Herlyn, M. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-397927-8.00011-7 · Cited by 106
Neil3, the final frontier for the DNA glycosylases that recognize oxidative damage
Liu, M., Doublié, S., & Wallace, S. S. (2013) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2012.12.003 · Cited by 87
Expression patterns of Neil3 during embryonic brain development and neoplasia
Hildrestrand, G. A., Neurauter, C. G., Diep, D. B., Castellanos, C. G., Krauss, S. J. K., Bjørås, M., & Luna, L. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-45 · Cited by 102
Cancer Treatment with Gene Therapy and Radiation Therapy
Kaliberov, S. A., & Buchsbaum, D. J. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-398342-8.00007-0 · Cited by 99
Røe, O. D., Anderssen, E., Helge, E., Pettersen, C. H., Olsen, K. S., Sandeck, H., Haaverstad, R., Lundgren, S., & Larsson, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006554 · Cited by 82
Revisiting determinants of prognosis in cutaneous melanoma
Weiss, S. A., Hanniford, D., Hernando, E., & Osman, I. (2015) · Cancer · doi:10.1002/cncr.29634 · Cited by 89
Bălăcescu, O., Bălăcescu, L., Tudoran, O. M., Todor, N., Rus, M., Buiga, R., Șușman, S., Fetică, B., Pop, L., Maja, L. I., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-246 · Cited by 84
Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity
Massaad, M. J., Zhou, J., Tsuchimoto, D., Chou, J. S., Jabara, H. H., Janssen, E., Glauzy, S., Olson, B. G., Morbach, H., Ohsumi, T. K., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85647 · Cited by 87
microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB
Giles, K. M., Brown, R. A. M., Ganda, C., Podgorny, M. J., Candy, P. A., Wintle, L. C., Richardson, K. L., Kalinowski, F. C., Stuart, L. M., Epis, M. R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9421 · Cited by 77
The butterfly effect in cancer: A single base mutation can remodel the cell
Hart, J. R., Zhang, Y., Liao, L., Ueno, L. A., Du, L., Jonkers, M., Yates, J. R., & Vogt, P. K. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424012112 · Cited by 89
NEIL3 Repairs Telomere Damage during S Phase to Secure Chromosome Segregation at Mitosis
Zhou, J., Chan, J., Lambelé, M., Yusufzai, T., Stumpff, J., Opresko, P. L., Thali, M., & Wallace, S. S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.020 · Cited by 75
Kamal, Y., Schmit, S. L., Hoehn, H. J., Amos, C. I., & Frost, H. R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3945 · Cited by 73
Røe, O. D., Anderssen, E., Sandeck, H., Christensen, T., Larsson, E., & Lundgren, S. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.03.016 · Cited by 78
Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq
Gerber, T., Willscher, E., Loeffler‐Wirth, H., Hopp, L., Schadendorf, D., Schartl, M., Anderegg, U., Camp, J. G., Treutlein, B., Binder, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13666 · Cited by 81
Maga, G., Crespan, E., Wimmer, U., van Loon, B., Amoroso, A., Mondello, C., Belgiovine, C., Ferrari, E. S., Locatelli, G. A., Villani, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811241106 · Cited by 72
Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter
Redmer, T. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0854-5 · Cited by 67
“These factors may also determine whether radiation therapy will be effective against BM arising from melanoma [156].”
BackgroundSaviozzi, S., Ceppi, P., Novello, S., Ghio, P., Iacono, M. L., Borasio, P., Cambieri, A., Volante, M., Papotti, M. G., Calogero, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2981 · Cited by 73
Molecular features and gene expression signature of metastatic colorectal cancer (Review)
Poturnajova, M., Furielova, T., Balintova, S., Schmidtova, S., Kučerová, L., & Matúšková, M. (2021) · Oncology Reports · doi:10.3892/or.2021.7961 · Cited by 76
Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma
DeSisto, J. A., Lucas, J. T., Xu, K., Donson, A. M., Lin, T., Sanford, B. L., Wu, G., Tran, Q. T., Hedges, D. J., Hsu, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25709-x · Cited by 67
Chk1 as a new therapeutic target in triple-negative breast cancer
Albiges, L. K., Goubar, A., Scott, V., Vicier, C., Lefèbvre, C., Alsafadi, S., Commo, F., Saghatchian, M., Lazar, V., Dessen, P., et al. (2014) · The Breast · doi:10.1016/j.breast.2014.02.004 · Cited by 71
Self-citationMelanoma sentinel node biopsy and prediction models for relapse and overall survival
Mitra, A., Conway, C., Walker, C., Cook, M. G., Powell, B., Lobo, S., Chan, M., Kissin, M. W., Layer, G. T., Smallwood, J. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605849 · Cited by 67
Bénard, J., Raguénez, G., Kauffmann, A., Valent, A., Ripoche, H., Joulin, V., Job, B., Danglot, G., Cantais, S., Robert, T., et al. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.07.002 · Cited by 73
Self-citationRedmer, T., Walz, I., Klinger, B., Khouja, S., Welte, Y., Schäfer, R., & Regenbrecht, C. R. A. (2017) · Oncogenesis · doi:10.1038/oncsis.2016.88 · Cited by 69
Song, W.-M., Agrawal, P., Von Itter, R., Fontanals-Cirera, B., Wang, M., Zhou, X., Mahal, L. K., Hernando, E., & Zhang, B. (2021) · Nature Communications · doi:10.1038/s41467-021-21457-0 · Cited by 62
Patterns of Expression of DNA Repair Genes and Relapse From Melanoma
Jewell, R., Conway, C., Mitra, A., Randerson‐Moor, J. A., Lobo, S., Nsengimana, J., Harland, M., Marples, M., Edward, S., Cook, M. G., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1521 · Cited by 68
Review and Cross-Validation of Gene Expression Signatures and Melanoma Prognosis
Schramm, S., Campain, A. E., Yang, J. Y. H., & Mann, G. J. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.305 · Cited by 69
Karras, P., Riveiro‐Falkenbach, E., Cañón, E., Tejedo, C., Calvo, T. G., Martínez-Herranz, R., Alonso‐Curbelo, D., Cifdaloz, M., Pérez‐Guijarro, E., Goméz-López, G., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.11.008 · Cited by 71
Leung, M., Rosen, D. B., Fields, S. Z., Cesano, A., & Budman, D. R. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00240 · Cited by 67
Bartolucci, R., Wei, J., Sánchez, J. J., Perez‐Roca, L., CHAIB-OUKADOUR, I., Puma, F., Farabi, R., Méndez, P., Roila, F., Okamoto, T., et al. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.007 · Cited by 69
Polymorphisms of Nucleotide Excision Repair Genes Predict Melanoma Survival
Li, C., Yin, M., Wang, L., Amos, C. I., Zhu, D. K., Lee, J. E., Gershenwald, J. E., Grimm, E. A., & Wei, Q. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.498 · Cited by 59
Role of RAD51AP1 in homologous recombination DNA repair and carcinogenesis
Pires, E., Sung, P., & Wiese, C. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.09.008 · Cited by 59
Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells
Gaddameedhi, S., Kemp, M. G., Reardon, J. T., Shields, J. M., Smith-Roe, S. L., Kaufmann, W. K., & Sancar, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0095 · Cited by 56
“In contrast, although there is some evidence linking a polymorphism in the excision repair gene XPD and susceptibility to cutaneous melanoma (20), there is little available data indicating that altered expression of excision repair genes contributes to melanoma, and indeed, a recent microarray analysis of mRNA express…”
BackgroundTargeting DNA repair for cancer treatment: Lessons from PARP inhibitor trials
Nambiar, D. K., Mishra, D., & Singh, R. P. (2023) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.028310 · Cited by 63
Liu, M., Imamura, K., Averill, A. M., Wallace, S. S., & Doublié, S. (2013) · Structure · doi:10.1016/j.str.2012.12.008 · Cited by 60
Széll, M., Danis, J., Bata‐Csörgõ, Z., & Kemény, L. V. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1803-z · Cited by 55
Wei, L., Lian, B., Zhang, Y., Li, W., Gu, J., He, X., & Xie, L. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-s1-s13 · Cited by 54
Neurauter, C. G., Luna, L., & Bjørås, M. (2012) · DNA repair · doi:10.1016/j.dnarep.2012.01.007 · Cited by 61
Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair
Budden, T., Davey, R. J., Vilain, R. E., Ashton, K. A., Braye, S. G., Beveridge, N. J., & Bowden, N. A. (2016) · Oncotarget · doi:10.18632/oncotarget.10902 · Cited by 52
Trappetti, V., Fazzari, J., Fernández-Palomo, C., Scheidegger, M., Volarević, V., Martin, O. A., & Djonov, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147755 · Cited by 58
Human RIF1 encodes an anti-apoptotic factor required for DNA repair
Wang, H., Zhao, A., Chen, L., Zhong, X. Z., Liao, J., Gao, M., Cai, M., Lee, D.-H., Li, J., Chowdhury, D., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp136 · Cited by 54
Anti-Cancer Activity of Curcumin on Multiple Myeloma
Mirzaei, H., Bagheri, H., Ghasemi, F., Khoi, J. M., Pourhanifeh, M. H., Heyden, Y. V., Mortezapour, E., Nikdasti, A., Jeandet, P., Khan, H. Z., et al. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200918113625 · Cited by 55
Srinivas, U. S., Dyczkowski, J., Beißbarth, T., Gaedcke, J., Mansour, W. Y., Borgmann, K., & Dobbelstein, M. (2015) · Oncotarget · doi:10.18632/oncotarget.3728 · Cited by 52
Tissue prognostic biomarkers in primary cutaneous melanoma
Mandalà, M., & Massi, D. (2014) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-013-1526-x · Cited by 49
Kazma, R., Babron, M., Gaborieau, V., Génin, E., Brennan, P., Hung, R. J., McLaughlin, J. R., Krokan, H. E., Elvestad, M. B., Skorpen, F., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs116 · Cited by 53
Self-citationWatson, A. J., Middleton, M. R., McGown, G., Thorncroft, M. R., Ranson, M., Hersey, P., McArthur, G. A., Davis, I. D., Thomson, D. B., Beith, J. M., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605015 · Cited by 48
Krakstad, C., Tangen, I. L., Hoivik, E. A., Halle, M. K., Berg, A., Werner, H. M., Ræder, M. B., Kusonmano, K., Zou, J. X., Øyan, A. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4955 · Cited by 47
Bais, M. V., Ozdener, G. B., Sonenshein, G. E., & Trackman, P. C. (2014) · Oncogene · doi:10.1038/onc.2014.147 · Cited by 51
Chakraborty, U., Dinh, T. A., & Alani, E. (2018) · Genetics · doi:10.1534/genetics.118.300923 · Cited by 48
Expression of DNA repair genes in ovarian cancer samples: Biological and clinical considerations
Ganzinelli, M., Mariani, P., Cattaneo, D., Fossati, R., Fruscio, R., Corso, S., Ricci, F., Broggini, M., & Damia, G. L. M. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.029 · Cited by 40
The biology behind prognostic factors of cutaneous melanoma
Spatz, A., Batist, G., & Eggermont, A. M. M. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328337fe8f · Cited by 45
Self-citationProfiles of brain metastases: Prioritization of therapeutic targets
Ferguson, S. D., Zheng, S., Xiu, J., Zhou, S., Khasraw, M., Brastianos, P. K., Kesari, S., Hu, J. L., Rudnick, J. D., Salacz, M. E., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31624 · Cited by 43
DNA repair: the culprit for tumor-initiating cell survival?
Mathews, L., Cabarcas‐Petroski, S., & Farrar, W. L. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9277-0 · Cited by 46
Genomic and transcriptomic landscape of conjunctival melanoma
Cisarova, K. V., Folcher, M., Zaoui, I. E., Gobert, R. P., Peter, V. G., Royer‐Bertrand, B., Zografos, L., Schalenbourg, A., Nicolas, M., Rimoldi, D., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009201 · Cited by 42
Laczny, C. C., Leidinger, P., Haas, J., Ludwig, N., Backes, C., Gerasch, A., Kaufmann, M., Vogel, B., Katus, H. A., Meder, B., et al. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-36 · Cited by 41
Gut microbiota imbalance and base excision repair dynamics in colon cancer
Ray, D., & Kidane, D. (2016) · Journal of Cancer · doi:10.7150/jca.15480 · Cited by 37
“Furthermore, Neil3 is highly expressed in embryonic stem cells as well as pluripotent cells in the brain [121] and human cancer cells [122].”
BackgroundWang, X., Wang, S., Zhou, L., Yu, L., & Lan-mei, Z. (2016) · Journal of Ovarian Research · doi:10.1186/s13048-016-0285-0 · Cited by 39
Bourseguin, J., Bonet, C., Renaud, E., Pandiani, C., Boncompagni, M., Giuliano, S., Pawlikowska, P., Karmous‐Benailly, H., Ballotti, R., Rosselli, F., et al. (2016) · Scientific Reports · doi:10.1038/srep36539 · Cited by 40
Self-citationSingle-nucleotide polymorphisms in DNA-repair genes and cutaneous melanoma
Figl, A., Scherer, D., Nagore, E., Bermejo, J. L., Estrada, R. B., Gast, A., Thirumaran, R. K., Planelles, D., Hemminki, K., Schadendorf, D., et al. (2010) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2010.06.011 · Cited by 37
Wang, Z., Liu, Z., Wu, X., Chu, S., Wang, J., Yuan, H., Roth, M., Yuan, Y., Bhatia, R., & Chen, W. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004414 · Cited by 36
Klattenhoff, A. W., Thakur, M. A., Chu, C. S., Ray, D., Habib, S. L., & Kidane, D. (2017) · Oncotarget · doi:10.18632/oncotarget.22896 · Cited by 41
Options of Therapeutics and Novel Delivery Systems of Drugs for the Treatment of Melanoma
Wang, H., Tran, T., Duong, K. T., Nguyen, T. B., & Le, U. M. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00775 · Cited by 36
Lugassy, C., Lazar, V., Dessen, P., van den Oord, J. J., Winnepenninckx, V. J. L., Spatz, A., Bagot, M., Bensussan, A., Janin, A., Eggermont, A. M. M., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.01.009 · Cited by 34
Self-citationMolecular therapy in support to radiotherapy
Dutreix, M., Cosset, J., & Sun, J. (2010) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2010.01.001 · Cited by 35
Gugatschka, M., Darnhofer, B., Grossmann, T., Schittmayer, M., Hortobagyi, D., Kirsch, A., Karpf, E., Brčić, L., Birner‐Gruenberger, R., & Karbiener, M. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001272 · Cited by 35
Zhao, Z., Gad, H., Benitéz‐Buelga, C., Sanjiv, K., Xiangwei, H., He, K., Feng, M., Zhao, Z., Berglund, U. W., Xia, Q., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1028 · Cited by 40
Tu, Z., Xu, B., Qu, C., Tao, Y., Chen, C., Hua, W., Feng, G., Chang, H., Liu, Z., Guo, L., et al. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0427-3 · Cited by 33
Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration
Rákosy, Z., Ecsedi, S., Tóth, R., Vízkeleti, L., Hernández‐Vargas, H., Lázár, V., Emri, G., Szatmári, I., Herceg, Z., Ádány, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054958 · Cited by 32
Nezos, A., Lembessis, P., Sourla, A., Pissimissis, N., Gogas, H. J., & Koutsilieris, M. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.009 · Cited by 36
Melanoma molecular classes and prognosis in the postgenomic era
Tremante, E., Ginebri, A., Monaco, E. L., Frascione, P., Filippo, F. D., Terrenato, I., Benevolo, M., Mottolese, M., Pescarmona, E. O., Visca, P., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70003-7 · Cited by 31
Makino, E., Fröhlich, L. M., Sinnberg, T. W., Kosnopfel, C., Sauer, B., Garbe, C., & Schittek, B. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2702-y · Cited by 34
Miao, H., Ren, Q., Li, H., Zeng, M., Chen, D. S., Xu, C., Chen, Y., & Wen, Z. (2022) · BMC Cancer · doi:10.1186/s12885-022-09314-9 · Cited by 35
Schrama, D., Scherer, D., Schneider, M. O., Zapatka, M., Bröcker, E., Schadendorf, D., Ugurel, S., Kumar, R., & Becker, J. C. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.35 · Cited by 33
Snyder, A., Nathanson, T. A., Funt, S., Ahuja, A., Buros, J. L., Hellmann, M., Chang, E., Aksoy, B., Al‐Ahmadie, H. A., Yusko, E. C., et al. (2018) · immuneACCESS · doi:10.21417/b7mg68 · Cited by 32
Hine, C., Li, H., Xie, L. H., Mao, Z., Seluanov, A., & Gorbunova, V. A. (2014) · Cell Cycle · doi:10.4161/cc.29016 · Cited by 31
Metadata
- Authors
- Kauffmann, A., Rosselli, F., Lazar, V, Winnepenninckx, V, Mansuet-Lupo, A., Dessen, P., van den Oord, J. J., Spatz, A., & Sarasin, A.
- Affiliations
- Université Paris-Sud (FR)
- Institut Gustave Roussy (FR)
- Maastricht University Medical Centre (NL)
- Corresponding author
- Sarasin, A
- Venue
- Oncogene
- Published
- 2007-09-24
- Volume
- 27
- Issue
- 5
- Pages
- 565-573
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2013996063
- Cited by
- 274
- References
- 35
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 10 · 2023: 15 · 2022: 14 · 2021: 23 · 2020: 24 · 2019: 7 · 2018: 16 · 2017: 22 · 2016: 15 · 2015: 17 · 2014: 16 · 2013: 12 · 2012: 15
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Université Paris Diderot
- Institut Gustave-Roussy
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- melanoma, metastasis, DNA repair pathways, DNA replication, gene expression signatures, prognostic factors, genetic stability, chemoresistance, radiotherapy resistance
- MeSH terms
- Cell Transformation, Neoplastic, DNA Repair, Humans, Melanoma, Skin Neoplasms, Gene Expression Regulation, Neoplastic, Gene Expression Profiling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.